INS1202
/ Insmed
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 10, 2025
Intrathecal delivery of INS1202 AAV9-SOD1-shRNA rescues hallmarks of neurodegeneration in a disease model of ALS and targets glia and neurons in the spinal cord and brain of non-human primates
(ASGCT 2025)
- "A 3-month GLP NHP toxicology study is nearing completion to evaluate safety in a larger number of animals, which will provide additional safety and tolerability data. Disease Focus of Abstract:Neuromuscular Disorders"
Amyotrophic Lateral Sclerosis • CNS Disorders • CHAT • GFAP
1 to 1
Of
1
Go to page
1